FDA greenlights Prenosis’ AI solution for sepsis diagnosis: is this a paradigm shift in healthcare?

In a landmark development poised to reshape the landscape of medical diagnostics, the U.S. Food and Drug Administration (FDA) has officially sanctioned Prenosis’ pioneering artificial intelligence (AI) tool designed for the early detection of sepsis.